Voice your opinion on congressional bill HR1199-118 and let lawmakers know your stance with UnPac!

Main Subject: Health

Facilitating Innovative Nuclear Diagnostics Act of 2023

This bill establishes separate payment requirements for diagnostic radiopharmaceuticals under the Medicare prospective payment system for hospital outpatient department services. The bill's requirements apply to diagnostic radiopharmaceuticals that have an average daily cost of $500 or more in 2024 and as adjusted based on a specified fee schedule factor in each year thereafter.

House committee actions Actions

Committee
May. 16 2024	Forwarded by Subcommittee to Full Committee by Voice Vote. Subcommittee Consideration and Mark-up Session Held
Mar. 10 2023	Referred to the Subcommittee on Health.

House floor actions Actions

IntroReferral

Feb. 27
2023

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Library of Congress Actions

IntroReferral
Feb. 27 2023	Introduced in House Introduced in House

House bill HR1199-118

Facilitating Innovative Nuclear Diagnostics Act of 2023

House bill HR1199-118

Facilitating Innovative Nuclear Diagnostics Act of 2023

Promote the cause!

Or use this QR code